Naproxen Tablet, Delayed Release
Product Images NDC 66267-373
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Naproxen (NDC 66267-373). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Clinical Pahrmacology (0778e9f1 B341 448c Ba26 Cfa4370e8123 02)
Dosage And Administration (0778e9f1 B341 448c Ba26 Cfa4370e8123 03)
66267 373 20
NuCare Pharmaceuticals, Inc. has a product labeled as Naproxen 500mg MFR NDC: 69097-852-07 with Lot: 000000 and expiration date of 00-00. The product is in the form of 20 Enteric-Coated Delayed-Release Tablets. Also, the product labeled as IH: 835 #20E-C D-R Tablets Mroensumg with Lot: 000000 and expiration date of 00-00 is manufactured by Selamm MFR NDC: 69097-852-07. The tablets are Capsule-Shaped White Tablet with LOT# 000000 de-bossed '1 11' on one side. It is advised to keep the product out of reach of children and store it at a controlled temperature of 68-77°F. For medical advice on side effects, contact a doctor or report it to FDA on 1-800-FDA-1088.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.